Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$480,171
+$118,118 QoQ
Shares Held
1,326
+28.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,218
of 3,140 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $20,079,575 across 8 Drug Manufacturers - General names. AMGN ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,238 | $8,681,475 | |
| 2 | JNJ |
Johnson & Johnson
|
22,094 | $5,611,213 | |
| 3 | ABBV |
AbbVie Inc.
|
9,774 | $2,459,529 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,797 | $1,130,414 | |
| 5 | PFE |
Pfizer Inc
|
42,927 | $1,033,682 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,326 | $480,171 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,527 | $376,085 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,430 | $307,006 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $480,171 | 1,326 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $362,053 | 1,029 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $334,183 | 1,021 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $304,493 | 1,079 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $297,637 | 1,066 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $286,314 | 919 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $213,464 | 819 | Shares | Sole | 2025-01-17 | |
| 2020-09-30 | $24,907 | 98 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||